List view / Grid view

News

Epidarex Capital launches Nodthera Limited

28 July 2016 | By Epidarex Capital

Epidarex Capital announces the launch of Nodthera Limited, a new biotech company focused on the discovery and development of novel inhibitors of the NLRP3 inflammasome...

Leukaemia study takes aim at therapy resistant proteins

28 July 2016 | By Caleb Radford, The Lead

Assessing a patient's levels of the P-glycoprotein soon after they start receiving Glivec therapy will help to predict that patient’s long-term response to the leukaemia drug, according to new research from SAHMRI and the University of Adelaide...

GlaxoSmithKline to invest £275 million in UK

27 July 2016 | By Niamh Louise Marriott, Digital Content Producer

The investment will be used for manufacturing of new respiratory and biopharmaceuticals, to be exported outside the UK to global markets...

New compounds could prevent epilepsy

22 July 2016 | By Niamh Louise Marriott, Digital Content Producer

Researchers have developed compounds that may prevent the development of epilepsy. In a new study, scientists found that these compounds prevented seizures and their damaging effects...

Glutamine-depriving drugs block bowel cancer tumour

21 July 2016 | By Niamh Louise Marriott, Digital Content Producer

A new scientific study using mice has identified why cancer cells depend on glutamine to reprogram their metabolism - and a way to starve them of it...